Can We Predict Response to Ketamine in Psychiatry?
Researchers, presenting at the American Psychiatric Association 2023 Annual Meeting, discussed recent findings on biomarkers for predicting ketamine treatment response. The session, titled “Emerging...
Conflict Between Available Data and the Real World of Bipolar Depression Treatment
In a session at the American Psychiatric Association 2023 Annual Meeting titled “Treatment of Bipolar Depression,” Michael Jay Gitlin, MD, gave an overview of...
The Latest Evolution of Repetitive TMS for Treatment-Resistant Depression
At the American Psychiatric Association 2023 Annual Meeting, Nolan Williams, MD, presented as part of a session titled “Advances in Non-Invasive Neuromodulation: Exploring rTMS...
Evidence of a Link Between Anemia and Schizophrenia Severity
Researchers discussed relationships between anemia and metabolic biochemical markers in patients with schizophrenia in a poster presented at the American Psychiatric Association 2023 Annual...